Position in CSTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,308,648
New position
Shares Held
348,371
first reported quarter
Ownership
1.14%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#19
of 175 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $76,192,428 across 12 Diagnostics & Research names. CSTL ranks #3 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,364,282 | $31,681,378 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
43,719 | $9,915,032 | |
| 3 | CSTL |
Castle Biosciences Inc
This page
|
348,371 | $8,308,648 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
13,440 | $6,738,278 | |
| 5 | A |
Agilent Technologies, Inc.
|
43,014 | $5,713,549 | |
| 6 | ICLR |
Icon PLC
|
19,993 | $3,472,984 | |
| 7 | VCYT |
Veracyte, Inc.
|
52,978 | $3,111,397 | |
| 8 | DHR |
Danaher Corp /De/
|
14,347 | $2,732,816 |
All Filings in CSTL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,308,648 | 348,371 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||